SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004125
Filing Date
2021-11-10
Accepted
2021-11-10 16:35:26
Documents
50
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rlyb-20210930.htm   iXBRL 10-Q 2054893
2 EX-31.1 rlyb-ex31_1.htm EX-31.1 19171
3 EX-31.2 rlyb-ex31_2.htm EX-31.2 19402
4 EX-32.1 rlyb-ex32_1.htm EX-32.1 11116
5 EX-32.2 rlyb-ex32_2.htm EX-32.2 11115
6 GRAPHIC img113857645_0.jpg GRAPHIC 66963
  Complete submission text file 0000950170-21-004125.txt   5314588

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlyb-20210930_pre.xml EX-101.PRE 223695
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlyb-20210930.xsd EX-101.SCH 31595
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rlyb-20210930_cal.xml EX-101.CAL 25214
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rlyb-20210930_def.xml EX-101.DEF 155980
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlyb-20210930_lab.xml EX-101.LAB 276515
12 EXTRACTED XBRL INSTANCE DOCUMENT rlyb-20210930_htm.xml XML 556137
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

IRS No.: 851083789 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40693 | Film No.: 211397249
SIC: 2834 Pharmaceutical Preparations